Sundar Kodiyalam

ASCIO Pharmaceuticals, Inc. manufactures pharmaceutical products. It specializes in gastroenterology, oncology, and urology. The company is headquartered in Alpharetta, GA.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY.

Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY.

ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA.

Vatera Healthcare Partners (Vatera Healthcare) is a venture capital subsidiary of Oikos Holdings LLC founded in 2007 by Michael Jaharis and Sundar Kodiyalam. The firm is headquartered in New York.

Part of Esperion Therapeutics, Inc., Talaria Therapeutics, Inc. researches and develops technology for treating cardiovascular disease. The company is based in West Conshohocken, PA. Talaria Therapeutics was acquired by Esperion Therapeutics, Inc. on September 30, 2000 for $20.32 million. The company was founded by Dennis I. Goldberg, Chuck G. Hadley.

EG 427 is a French biotechnology company that specializes in gene therapy. The location of the company is unknown. The company was founded by Alberto Epstein, François Giuliano, and Philippe O. Chambon, with Philippe O. Chambon serving as CEO since incorporation.

Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington.